Sucralfate and Rinvoq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Rinvoq (upadacitinib). Common drug interactions include joint dislocation among females and dry skin among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Rinvoq. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Rinvoq?

Rinvoq has active ingredients of upadacitinib. eHealthMe is studying from 47,375 Rinvoq users. Check the latest studies of Rinvoq.



On Jul, 16, 2026

42 people who take Sucralfate and Rinvoq together, and have interactions are studied.

Sucralfate and Rinvoq drug interactions.

What are the common drug interactions of Sucralfate and Rinvoq, by gender? *:

female:

  1. Joint dislocation (a joint position is changed from normal position)
  2. Fall
  3. Pain
  4. Troponin increased
  5. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  6. Nausea (feeling of having an urge to vomit)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Septic shock (shock due to blood infection)
  9. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  10. Pain in extremity

male:

  1. Dry skin
  2. Precancerous skin lesion
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  5. Dizziness
  6. Memory impairment
  7. Paranasal sinus discomfort
  8. Ulcer haemorrhage (bleeding ulcer)

What are the common drug interactions of Sucralfate and Rinvoq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pain
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  4. Vulval abscess

50-59:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)

60+:

  1. Pneumonia
  2. Foot deformity (functional disability of foot)
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Dyspnoea (difficult or laboured respiration)
  5. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  6. Pain in extremity
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Peripheral swelling
  9. Renal tubular necrosis (death of kidney tubules)
  10. Skin lesion

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 31 people, 73.81%
  2. High Blood Pressure: 7 people, 16.67%
  3. High Blood Cholesterol: 5 people, 11.90%
  4. Depression: 4 people, 9.52%
  5. Neuralgia (pain in one or more nerves): 3 people, 7.14%
  6. Gastric Ulcer (stomach ulcer): 3 people, 7.14%
  7. Diarrhea: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Rinvoq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sucralfate and Rinvoq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rinvoq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rinvoq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate and upadacitinib (the active ingredients of Sucralfate and Rinvoq, respectively), and Sucralfate and Rinvoq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: